Healthpeak Properties (NYSE: DOC) has recently received a number of price target changes and ratings updates:
- 12/22/2025 – Healthpeak Properties had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/15/2025 – Healthpeak Properties was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $17.00 price target on the stock, down previously from $21.00.
- 12/15/2025 – Healthpeak Properties had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/15/2025 – Healthpeak Properties had its price target lowered by analysts at Evercore ISI from $22.00 to $21.00. They now have an “outperform” rating on the stock.
- 12/8/2025 – Healthpeak Properties had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
- 12/1/2025 – Healthpeak Properties was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
- 11/25/2025 – Healthpeak Properties had its price target raised by analysts at Wells Fargo & Company from $18.00 to $19.00. They now have an “equal weight” rating on the stock.
- 11/24/2025 – Healthpeak Properties had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/18/2025 – Healthpeak Properties had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/12/2025 – Healthpeak Properties was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating.
- 11/12/2025 – Healthpeak Properties had its price target lowered by analysts at Robert W. Baird from $21.00 to $20.00. They now have an “outperform” rating on the stock.
Healthpeak Properties Announces Dividend
The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 7.6%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio (DPR) is currently -2,440.00%.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Further Reading
- Five stocks we like better than Healthpeak Properties
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- Wall Street Stockpicker Names #1 Stock of 2026
- Your “birthright claim” just got activated
- Drop these 5 stocks now!
- Terrifying reason Trump killed the U.S. penny?
Receive News & Ratings for Healthpeak Properties Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties Inc and related companies with MarketBeat.com's FREE daily email newsletter.
